Fig. 2: Age correlated overall survival according to secondary resection in the RAS wild-type population. | British Journal of Cancer

Fig. 2: Age correlated overall survival according to secondary resection in the RAS wild-type population.

From: Efficacy of FOLFIRI plus cetuximab vs FOLFIRI plus bevacizumab in 1st-line treatment of older patients with RAS wild-type metastatic colorectal cancer: an analysis of the randomised trial FIRE-3

Fig. 2: Age correlated overall survival according to secondary resection in the RAS wild-type population.The alternative text for this image may have been generated using AI.

For survival times Kaplan–Meier estimation medians and 95% CIs are given. OS median overall survival, wt wild-type.

Back to article page